Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

FDA clears Pfizer’s leukaemia drug Besponsa

The breakthrough treatment is the first CD22-targeted ADC to be approved in the US

- PMLiVE

emotive appoints head of talent

Adela Zafar moves from NAVBLUE to take up the newly-created role

- PMLiVE

Lynparza approval sets up tighter bout with PARP rivals

US regulator gives AZ the go-ahead for a new maintenance indication and formulation

- PMLiVE

Does your content have enough content?

Finding the balance in health and science communications

- PMLiVE

Communicating beyond the data

Relying on alternative methods to deliver results

- PMLiVE

Insights are our digital media bag

Life at Four Health Media has been pretty busy this last 12 months. We have a new name (we were previously Four MSA), our team has grown, we have new...

Four Agency Worldwide

- PMLiVE

Biocon backs away from biosimilar filings in Europe

EMA asks biotech to withdraw Herceptin and Neulasta biosimilar filings

- PMLiVE

Trump disbands CEO councils after more defections

J&J’s Gorsky resigns following Trump's remark about Charlottesville

US health reforms

Is the stage set for price controls in the US?

- PMLiVE

Uniting around a common goal

The importance of the multidiscipline team

- PMLiVE

Baird Capital backs Prescient Healthcare Group

Group invests in the consultancy by dipping into its $310m fund

Orchard Therapeutics appoints Mark Rothera as CEO

He joins from PTC Therapeutics

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links